Venmax Drugs & Pharmaceuticals Ltd

NSE: VENMAX · BSE: 531015 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹14.89
Market cap: ₹13.08 Cr
Revenue (annual): ₹8.02 Cr
Net profit (annual): ₹0.25 Cr
P/E (TTM): 46.7×Sector 47.3×
Promoter holding: 10.46%-3.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 2 Board Meeting Date 2 Acquisition 2 Other Announcement 1 Financial Results 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

24 Aug 2026 12:51 IST BSE

Board Meeting Date

Venmax Drugs & Pharmaceuticals Board Meeting Date

Venmax Drugs & Pharmaceuticals scheduled a board meeting for August 31, 2026. The board will approve the 37th Annual Report and fix details for the Annual General Meeting.

Read the filing ↗

1 Aug 2026 15:41 IST BSE

Board Meeting Date

Venmax Drugs & Pharmaceuticals Board Meeting Date

Venmax Drugs and Pharmaceuticals has scheduled a board meeting for August 7, 2026, to consider quarterly financial results and forfeiture of partly paid-up share warrants.

Read the filing ↗